ENALAPRIL/LERCANIDIPINE ZENTIVA 20 mg/20 mg, film-coated tablet 30 tablets
Active ingredients: Lercanidipine hydrochloride, Lercanidipine, Enalapril maleate, Enalapril
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENALAPRIL/LERCANIDIPINE ZENTIVA 20 mg/20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Feb 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61937984CIP73022712CIP133400930227121Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE D'ÉNALAPRILcomprimé | 20 mg · un comprimé | SA |
| CHLORHYDRATE DE LERCANIDIPINEcomprimé | 20 mg · un comprimé | SA |
| ÉNALAPRILcomprimé | 15,28 mg · un comprimé | FT |
| LERCANIDIPINEcomprimé | 18,88 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.